Antisense therapy directed to protein kinase C-alpha (affinitak, LY900003/ISIS 3521): Potential role in breast cancer (Q35117571)
scientific article published on April 1, 2003
Language:
(P31) (Q13442814)
(P304) 30-33
(P407) (Q1860)
(P433) 2 Suppl 3
(P478) 30
(P577) Tuesday, April 1, 2003
(P921) (Q162555)
(P1433) (Q14330412)
(P1476) "Antisense therapy directed to protein kinase C-alpha (Affinitak, LY900003/ISIS 3521): potential role in breast cancer" (language: en)
"Antisense therapy directed to protein kinase C-alpha (affinitak, LY900003/ISIS 3521): Potential role in breast cancer" (language: en)
(P2093) Debasish Roychowdhury
Michael Lahn
(P13046) (Q7318358)
other details
description scientific article published on April 1, 2003

External Links